HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

被引：26

作者：

Grebe, Eduard ^{[1
,2
]}

Busch, Michael P. ^{[1
,2
]}

Notari, Edward P. ^{[3
,4
]}

Bruhn, Roberta ^{[1
,2
]}

Quiner, Claire ^{[1
,5
]}

Hindes, Daniel ^{[1
]}

Stone, Mars ^{[1
,2
]}

Bakkour, Sonia ^{[1
,2
]}

Yang, Hong ^{[6
]}

Williamson, Phillip ^{[7
]}

Kessler, Debra ^{[8
]}

Reik, Rita ^{[9
]}

Stramer, Susan L. ^{[3
,4
]}

Glynn, Simone A. ^{[10
]}

Anderson, Steven A. ^{[6
]}

Williams, Alan E. ^{[6
]}

Custer, Brian ^{[1
,2
]}

机构：

[1] Vitalant Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA

[2] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA

[3] Amer Red Cross, Sci Affairs, Rockville, MD USA

[4] Amer Red Cross, Sci Affairs, Gaithersburg, MD USA

[5] RTI Int, Res Triangle Pk, NC USA

[6] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA

[7] Creat Testing Solut, Tempe, AZ USA

[8] New York Blood Ctr, New York, NY 10021 USA

[9] OneBlood, St Petersburg, FL USA

[10] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA

来源：

BLOOD | 2020年 / 136卷 / 11期

基金：

美国国家卫生研究院;

关键词：

RESIDUAL RISK; PREVALENCE; INFECTION; TRANSMISSION; DISPARITIES; DONATIONS; ANTIBODY; CANADA; HCV;

D O I：

10.1182/blood.2020007003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In 2015, the US Food and Drug Administration published revised guidance that recommended a change in blood donor deferral of men who have sex with men (MSM) from an indefinite to a 12-month deferral since the donor last had sex with a man. We assessed whether HIV incidence in first-time blood donors or associated transfusion risk increased. Donations in 4 major blood collection organizations were monitored for 15 months before and 2 years after implementation of the 12-month MSM deferral policy. HIV-positive donations were classified as recently acquired or bng-term using a recent infection testing algorithm and incidence in both periods estimated. Residual transfusion transmission risk was estimated by multiplying incidence by the length of the infectious window period. The latter was estimated using a model based on infectious dose and the sensitivity of nucleic acid testing. Factors associated with incident infection in each period were assessed using Poisson regression. Overall HIV incidence in first-time donors before implementation of the 12-month MSM deferral was estimated at 2.62 cases per 100000 person-years (10(5) PY) (95% credible interval [CI], 1.53-3.93 cases/10(5) PY), and after implementation at 2.85 cases/10(5) PY (95% CI, 1.96-3.93 cases/10(5) PY), with no statistically significant change. In male first-time donors, the incidence difference was 0.93 cases/10(5) PY (95% CI, -1.74-3.58 cases/10(5) PY). The residual risk of HIV transfusion transmission through components sourced from first-time donors was estimated at 0.32 transmissions per million (10(6)) packed red blood cell transfusions (95% CI, 0.29-0.65 transmissions/10(6) transfusions) before and 0.35 transmissions/10(5) transfusions (95% CI, 0.31-0.65 transmissions/10(6) transfusions) after implementation. The difference was not statistically significant. Factors associated with incident infection were the same in each period. We observed no increase in HIV incidence or HIV transfusion transmission risk after implementation of a 12-month MSM deferral policy.

引用

页码：1359 / 1367

页数：9

共 29 条

[1]

Belov AA, 2020, TRANSFUSION

[2] Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios [J].

Bruhn, Roberta ;

Lelie, Nico ;

Custer, Brian ;

Busch, Michael ;

Kleinman, Steven .

TRANSFUSION, 2013, 53 (10) :2399-2412

[3]

Centers for Disease Control and Prevention, 2019, HIV SURV REP

[4]

Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Division of HIV/AIDS Prevention, 2018, HIV SO US

[5]

Cerus Corporation, 2016, INTERCEPT BLOOD SYST

[6] Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States [J].

Crowder, Lauren A. ;

Steele, Whitney R. ;

Notari, Edward P. ;

Hopkins, Courtney K. ;

Lima, Jose L. O. ;

Foster, Gregory A. ;

Townsend, Rebecca L. ;

Krysztof, David E. ;

Dodd, Roger Y. ;

Stramer, Susan L. .

TRANSFUSION, 2017, 57 (02) :404-411

[7] HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern [J].

Custer, Brian ;

Quiner, Claire ;

Haaland, Richard ;

Martin, Amy ;

Stone, Mars ;

Reik, Rita ;

Steele, Whitney R. ;

Kessler, Debra ;

Williamson, Phillip C. ;

Anderson, Steven A. ;

Williams, Alan E. ;

Raymond, Henry F. ;

McFarland, Willi ;

Robinson, William T. ;

Glick, Sara ;

Sey, Kwa ;

Melton, C. David ;

Glynn, Simone A. ;

Stramer, Susan L. ;

Busch, Michael P. .

BLOOD, 2020, 136 (11) :1351-1358

[8] Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety [J].

Custer, Brian ;

Stramer, Susan L. ;

Glynn, Simone ;

Williams, Alan E. ;

Anderson, Steven A. .

TRANSFUSION, 2016, 56 (06) :1499-1502

[9] Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 [J].

Dodd, Roger Y. ;

Crowder, Lauren A. ;

Haynes, James M. ;

Notari, Edward P. ;

Stramer, Susan L. ;

Steele, Whitney R. .

TRANSFUSION MEDICINE REVIEWS, 2020, 34 (02) :81-93

[10]

Gen-Probe, 2012, PROCLEIX ULTRIO PLUS

← 1 2 3 →